Small CGG repeat expansion alleles of FMR1 gene are associated with parkinsonism
D Z Loesch1, M S Khaniani, H R Slater
1School of Psychological Science, La Trobe University, Melbourne/Bundoora, Victoria, Australia. d.loesch@latrobe.edu.au
Abstract:
Fragile X-associated tremor/ataxia syndrome (FXTAS) affects older males carrying premutation, that is, expansions of the CGG repeat (in the 55-200 range), in the FMR1 gene. The neurological changes are linked to the excessive FMR1 messenger RNA (mRNA), becoming toxic through a 'gain-of-function'. Because elevated levels of this mRNA are also found in carriers of the smaller expansion (grey zone) alleles, ranging from 40 to 54 CGGs, we tested for a possible role of these alleles in the origin of movement disorders associated with tremor. We screened 228 Australian males affected with idiopathic Parkinson's disease and other causes of parkinsonism recruited from Victoria and Tasmania for premutation and grey zone alleles. The frequencies of either of these alleles were compared with the frequencies in a population-based sample of 578 Guthrie spots from consecutive Tasmanian male newborns (controls). There was a significant excess of premutation carriers (Fisher's exact test p = 0.006). There was also a more than twofold increase in grey zone carriers in the combined sample of the Victorian and Tasmanian cases, with odds ratio (OR ) = 2.36, and 95% confidence intervals (CI): 1.20-4.63, as well as in Tasmanian cases only (OR = 2.33, 95% CI: 1.06-5.13), compared with controls. The results suggest that the FMR1 grey zone alleles, as well as premutation alleles, might contribute to the aetiology of disorders associated with parkinsonism.
Insights
Fragile X-associated tremor/ataxia syndrome (FXTAS) is linked to FMR1 gene premutation alleles. This study found that both premutation and smaller "grey zone" FMR1 alleles are more common in males with parkinsonism, suggesting a role in the condition's development.
Area of Science:
- Neurogenetics
- Movement Disorders
Background:
- Fragile X-associated tremor/ataxia syndrome (FXTAS) is associated with FMR1 gene premutation alleles (55-200 CGG repeats).
- Neurological issues in FXTAS are linked to toxic gain-of-function from excessive FMR1 messenger RNA (mRNA).
- Elevated FMR1 mRNA levels are also observed in carriers of smaller expansion
- grey zone
- alleles (40-54 CGGs).
Purpose of the Study:
- To investigate the potential role of FMR1 premutation and grey zone alleles in the etiology of parkinsonism.
- To determine if these alleles are more prevalent in males diagnosed with idiopathic Parkinson's disease or other parkinsonian disorders.
Main Methods:
- Screening of 228 Australian males with parkinsonism for FMR1 premutation and grey zone alleles.
- Comparison of allele frequencies in cases against a population-based control group (578 Tasmanian male newborns).
- Statistical analysis using Fisher's exact test and calculation of odds ratios (OR) with 95% confidence intervals (CI).
Main Results:
- A significant excess of FMR1 premutation carriers was found in the parkinsonism group (p = 0.006).
- A more than twofold increase in grey zone allele carriers was observed in the combined case sample (OR = 2.36, 95% CI: 1.20-4.63).
- This increase in grey zone carriers was also significant in Tasmanian cases only (OR = 2.33, 95% CI: 1.06-5.13).
Conclusions:
- FMR1 premutation alleles are significantly associated with parkinsonism.
- FMR1 grey zone alleles may also contribute to the development of parkinsonism.
- These findings suggest a potential genetic link between FMR1 expansions and movement disorders like Parkinson's disease.
Related Concept Videos
Parkinson Disease l: Introduction
Parkinson Disease ll: Pathophysiology
Alterations in Muscle Tone lll
Huntington Disease l: Introduction
Parkinson's Disease: Overview
Comparing Copy Number Variations and SNPs
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...


